{
Matthew Weston

People

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-242025-04-242025-04-252025-04-252133221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-242025-04-242025-04-252025-04-252133221100
Download SVG
Download PNG
Download CSV

ubs lowers merck price target but maintains buy rating

UBS has reduced its price target for Merck KGaA from 190 to 180 euros while maintaining a "Buy" rating. Analyst Matthew Weston has adjusted his earnings estimates, reflecting a more cautious outlook for Electronics sales and the Life Science segment's margin.
boerse.de
Euro MERCK KGaA DEU Matthew Weston
Finance & Economy, Market Report
12:21 07.03.2025

ubs lowers merck target price but maintains buy rating

UBS AG has reduced its target price for Merck KGaA from €190 to €180 while maintaining a "Buy" rating. Analyst Matthew Weston has adjusted earnings estimates, anticipating more cautious Electronics sales and Life Science margins. Following this analysis, Merck shares dropped 4.1% to €135.50, reflecting a potential upside of 32.84% to the new target.
finanzen.at
Euro MERCK KGaA DEU CHE Matthew Weston
Finance & Economy, Market Report
12:13 07.03.2025

UBS maintains buy rating for Merck KGaA with target price of 190 euros

UBS has maintained a "Buy" rating for Merck KGaA, setting a target price of 190 euros following the company's solid quarterly results, which met market expectations. Analyst Matthew Weston noted that the outlook for 2025 aligns with consensus estimates. The current share price stands at 140.45 euros, reflecting a 2.52% increase.
finanzen.net
Euro MERCK KGaA UBS AG DEU CHE Matthew Weston
Finance & Economy, Market Report
14:44 06.03.2025

UBS maintains buy rating for Merck with target price of 190 euros

UBS AG has maintained a "Buy" rating for Merck KGaA, setting a target price of 190 euros after the company reported solid quarterly results. Following this analysis, Merck shares rose by 2.0% to EUR 139.90, indicating a potential upside of 35.81% compared to the target price.
finanzen.ch
Euro MERCK KGaA UBS AG DEU Matthew Weston
Finance & Economy, Market Report
10:43 06.03.2025

UBS maintains buy rating for Merck shares with target price of 190 euros

UBS AG has maintained a "Buy" rating for Merck KGaA, setting a target price of 190 euros following the company's solid quarterly results, which met market expectations. Analyst Matthew Weston noted that the outlook for 2025 aligns with consensus estimates. Merck's share price rose by 2.0% to EUR 139.90, indicating a potential upside of 35.81% compared to the target price.
finanzen.net
Euro MERCK KGaA UBS AG DEU Matthew Weston
Finance & Economy, Market Report
10:28 06.03.2025

UBS maintains buy rating for Merck KGaA with 190 euro price target

UBS has maintained its "Buy" rating for Merck KGaA, setting a price target of 190 euros following the company's quarterly results, which met market expectations. Analyst Matthew Weston noted that the outlook for 2025 aligns with consensus estimates, reflecting solid performance.
boerse.de
Euro MERCK KGaA DEU Matthew Weston Thomas Müller Hubert Dichtl Show more
Finance & Economy, Market Report
10:00 06.03.2025

UBS maintains buy rating for Merck KGaA with price target of 190 euros

UBS has maintained its "Buy" rating for Merck KGaA, setting a price target of 190 euros ahead of the company's fourth quarter 2024 results. Analyst Matthew Weston noted that investor caution could lead to positive surprises in the upcoming earnings report.
boerse.de
Euro MERCK KGaA DEU Matthew Weston
Finance & Economy, Market Report
17:32 27.02.2025

ubs maintains buy rating for merck with target price of 190 euros

UBS has maintained a "Buy" rating for Merck KGaA, setting a target price of 190 euros ahead of the fourth-quarter results for 2024. Despite a recent 1.2% decline in share price to EUR 135.05, there is potential for a 40.69% increase based on the target. Year-to-date, Merck's shares have decreased by 3.5%.
finanzen.at
Euro MERCK KGaA DEU CHE Matthew Weston
Finance & Economy, Market Report
17:22 27.02.2025

ubs maintains buy rating for merck shares with price target of 190 euros

UBS AG has maintained a "Buy" rating for Merck KGaA shares, setting a price target of 190 euros ahead of the fourth quarter 2024 results. Analyst Matthew Weston noted that despite a recent decline in share price to 135.05 euros, there is potential for positive surprises in the upcoming earnings report.
finanzen.net
Euro MERCK KGaA DEU Matthew Weston
Finance & Economy, Market Report
16:58 27.02.2025

ubs upgrades astrazeneca to buy citing strong sales potential through 2030

UBS has upgraded AstraZeneca from "Neutral" to "Buy," raising its price target from 11,500 to 14,200 pence. Analyst Matthew Weston highlighted the company's promising pipeline, projecting an additional USD 17.6 billion in sales by 2030, contingent on successful trial outcomes for seven key drugs in 2025. Shares rose by 1.37% to GBP 119.64 following the announcement.
finanzen.net
British Pound Sterling Euro AstraZeneca PLC CHE GBR Matthew Weston
Finance & Economy, Market Report
13:25 13.02.2025
Trending
Subcategory
Corporate News Industry Trends Stock Market Updates Retail and Consumer Goods Global Financial Events Finance Mergers & Acquisitions Global Trade Developments Industry Mergers & Acquisitions Central Bank Actions CEO Changes Banking Regulations Supply Chain Management Startups & Entrepreneurship Energy Sector Developments Government Economic Policies Workplace Trends AI Innovations Cryptocurrency Trends Market Analysis and Predictions Financial Scams and Security
Countries:
USA CHN GBR IND CHE CAN JPN FRA DEU MEX RUS SGP BRA ZAF AUT ARE SAU ITA IDN IRL
Companies:
The Goldman Sachs Group, Inc. Bank of America Corporation Apple Inc. Alphabet Inc. Barclays PLC Tesla, Inc. Wells Fargo & Company Citigroup Inc. Deutsche Bank RV Global PP Commerzbank AG Lloyds Banking Group plc PepsiCo, Inc. BNP Paribas SA Google Inc. NVIDIA Corporation UBS Group AG Wix.com Ltd. BP Castrol K.K. Valvoline Inc. Bosch Limited
Currencies:
United States Dollar Euro Chinese Yuan British Pound Sterling Swiss Franc Indian Rupee Japanese Yen Indonesian Rupiah Canadian Dollar Russian Ruble South Korean Won United Arab Emirates Dirham Offshore Chinese Yuan Ghanaian Cedi Hungarian Forint Albanian Lek Brazilian Real Singapore Dollar Qatari Riyal Jordanian Dinar
People:
Donald Trump Elon Musk Warren Buffett Sergey Brin Larry Page Goldman Sachs Kelvin Taylor Carsten Fritsch Christopher Chandler Scott Bessent Martin Schlegel Jerome Powell Kubra Khan Joe Biden Volkmar Baur Christopher Wallerstedt Brian Moynihan Airlangga Hartarto Francesco Gaetano Caltagirone Leonardo Del Vecchio

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.